Karen J. Wilson, SVP, Finance & PAO at Jazz Pharmaceuticals plc (JAZZ), sold 3,000 shares at $175.00 ($525K) on 2014-09-11, disclosed to the SEC on 2014-09-15.
Scheduled sale ($525k) by SVP, Finance & PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2018-05-15 | $620K | — | Filing → |
| JAZZ | SELL | 2018-04-12 | $604K | — | Filing → |
| JAZZ | SELL | 2017-04-27 | $204K | — | Filing → |